SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-299373
Filing Date
2022-12-06
Accepted
2022-12-06 16:06:08
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d397102d8ka.htm   iXBRL 8-K/A 27237
2 EX-99.1 d397102dex991.htm EX-99.1 69332
6 GRAPHIC g397102g1207000552699.jpg GRAPHIC 2334
  Complete submission text file 0001193125-22-299373.txt   240053

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inab-20221110.xsd EX-101.SCH 2835
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE inab-20221110_lab.xml EX-101.LAB 19444
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inab-20221110_pre.xml EX-101.PRE 12131
8 EXTRACTED XBRL INSTANCE DOCUMENT d397102d8ka_htm.xml XML 4244
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Filer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39692 | Film No.: 221447693
SIC: 2836 Biological Products, (No Diagnostic Substances)